$RKLB

Clevenger Marvin Bradford sold $1.0M of RKLB

Clevenger Marvin Bradford (President, Rocket Lab USA, Inc) sold 15,051 shares of Rocket Lab Corp (RKLB) at an average of $69.63 ($69.53–$71.17, $1.05M total) across 3 trades on 2026-08-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Clevenger Marvin Bradford
Published Aug 26, 2026, 11:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 11:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosed sale is the first public notice of the transaction, offering new data for investors.

02

Market read

Provides fresh insider‑sale information; modest impact expected on RKLB price.

03

What to watch

Potential upcoming capital raise or strategic shift not disclosed; sale may free liquidity for future actions.

Relevance 5/10Novelty 6/10Timing: filing disclosed on 2026-08-26

Background

SEC Form 4 filing reports an insider transaction by Rocket Lab's President.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

President Marvin Bradford sold 15,051 shares (~$1.05M) via a 10b5-1 plan, reducing his stake to 458,924 shares.

Expected impact

Potential short-term downward pressure, likely limited to a few basis points.

Evidence & confidence

The sale is disclosed for the first time, but $1M is small for a mid‑cap; market may price it in quickly.

Market effects

Minimal impact on aerospace & defense sector; similar insider sales have not moved the sector historically.

No regional effect; company is US‑listed.

Limited to investors tracking Rocket Lab; no broader market relevance.

Counterpoint

The sale could be routine under a pre‑arranged plan, not a negative signal.

Key entities

  • Rocket Lab Corp

    US‑listed aerospace manufacturer (ticker RKLB).

  • Marvin Bradford

    President of Rocket Lab USA, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Is RKLB Stock A Buy Or A High-Beta Trap?

Rocket Lab (RKLB) trades at $66, down 56% from its 52-week high, with a high P/S ratio. Q2 2026 revenue was $234M, up 62% YoY, mainly from Space Systems. Neutron rocket launch and Iridium acquisition are delayed. Backlog is $2.36B. Management expects slow growth from Iridium.

$RKLBHighAI 8/10

Rocket Lab Falls 6% as SpaceX Flags Iridium Deal to the FCC, Intuitive Machines Slides 5%

Rocket Lab (RKLB) fell 6% to $63.82 after SpaceX filed an FCC complaint against Iridium, which could impact Rocket Lab's $8B acquisition. The deal's variable exchange ratio ties Iridium payouts to Rocket Lab's share price, amplifying regulatory risks. Intuitive Machines (LUNR) and AST SpaceMobile (ASTS) also slid 5% and 6% respectively, following broader sector weakness.

$RKLBHighAI 9/10

Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab (RKLB), a smaller competitor to SpaceX (SPCX), has developed HASTE, a suborbital launch vehicle for hypersonic testing, primarily for the Department of Defense. HASTE offers lower-cost, frequent testing, generating higher revenue per flight than standard Electron launches. Rocket Lab has secured around $500 million in HASTE contracts, contributing significantly to its projected 2026 revenue. The company also operates in satellite manufacturing and plans to expand with the acquisition

$INTCHighAI 8/10

Why Are Nasdaq, Dow Futures Trading Mixed Premarket? INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

U.S. stock futures were mixed on Tuesday, with Nasdaq and Russell 2000 futures up 0.1%, Dow futures down 0.1%, and S&P 500 futures flat. Investors await July CPI data and geopolitical tensions impact sentiment. Key earnings reports include SMCI, CRWV, CAVA, LITE, and SLS. NVDA labeled AI data centers as investable assets, INTC upsized its share sale to $20B, and RIOT secured a $9.1B deal. RKLB shares fell despite a revenue beat, ASTS extended selloff, and SPCX faced lockup expiration pressures.

$RKLBMedAI 8/10

Rocket Lab Stock: Bull vs. Bear

Rocket Lab (RKLB +2.04%) reported record revenue of $234M in Q2 2026, up 62% YoY, with a backlog of $2.36B. The company secured U.S. Space Force contracts but delayed its Neutron rocket launch. Despite growth, it trades at 51x sales and reported a $49M net loss in Q2. Neutron's success is critical for future profitability.